Invention Grant
- Patent Title: SSAO inhibitors and use thereof
-
Application No.: US17737580Application Date: 2022-05-05
-
Publication No.: US11964942B2Publication Date: 2024-04-23
- Inventor: Zaifang Ren , Xuefeng Sun , Qing Xu
- Applicant: Eccogene (Shanghai) Co., Ltd.
- Applicant Address: CN Shanghai
- Assignee: Eccogene (Shanghai) Co., Ltd.
- Current Assignee: Eccogene (Shanghai) Co., Ltd.
- Current Assignee Address: CN Shanghai
- Agency: COOLEY LLP
- Agent Chen Chen
- The original application number of the division: US17082323 2020.10.28
- Main IPC: C07D211/46
- IPC: C07D211/46 ; C07C317/32 ; C07D211/32 ; C07D307/14 ; C07D309/06 ; C07D319/12
Abstract:
The application relates to a compound of Formula (I′) or (I):
or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of Formula (I′) or (I), and a method of treating or preventing a disease in which SSAO plays a role.
or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of Formula (I′) or (I), and a method of treating or preventing a disease in which SSAO plays a role.
Public/Granted literature
- US20230026801A1 SSAO INHIBITORS AND USE THEREOF Public/Granted day:2023-01-26
Information query
